You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A human monoclonal antibody therapy for treatment of hantavirus cardiopulmonary syndrome

    SBC: CELDARA MEDICAL, LLC            Topic: NIAID

    PROJECT SUMMARY Rodent-borne viral outbreaks are increasing in both frequency and impact. As weather patterns evolve, rodent populations are affected and may multiply in areas where increased contact with humans results in infection. Hantaviruses, including Andes (ANDV) and Sin Nombre (SNV), are transmitted through the excreta of infected rodents and, when aerosolized, infect humans. In the Americ ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  2. PARCA (a digital tool) to improve Justice and Health

    SBC: Q2I, LLC            Topic: NIDA

    PROJECT SUMMARY/ABSTRACT Nearly 4.4 million individuals are on community supervision in the United States, with the majority (about 80%) being supervised under probation.1 Justice involved persons (JIPs) have a 474% increased lifetime experience with heroin, a 303% increased use of OxyContin in the last 12 months, and a 256% increased use in pain medication in the last 12 months, compared to the g ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  3. BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline

    SBC: SYNCHROHEALTH LLC            Topic: NIA

    PROJECT SUMMARY Clinical Need: Sarcopenia and frailty represent significant and growing clinical challenges whose rates increase with age, and place patients at risk for functional decline, institutionalization, or death. Resistance exercises are strongly recommended in this age group to promote muscle regeneration and strength and are routinely a part of evidence-based home exercise programs pres ...

    STTR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  4. Ultrasound-coupled Electrical Impedance Tomography for Sarcopenia Assessment

    SBC: RYTEK MEDICAL INC            Topic: NIA

    PROJECT SUMMARY/ABSTRACT Clinical Need: The coming decades promise a revolution in the personalized treatment for patients with breast cancer, including approaches to minimize collateral damage of curative. However, to help facilitate this, the academic and industrial clinical research communities need improved diagnostic biomarkers to assess the presence of muscle diseases such as sarcopenia. Onc ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
  5. Low Cost Blast Test Surrogate

    SBC: CREARE LLC            Topic: DHA22B001

    Blast-induced Traumatic Brain Injury (TBI) is a major threat to the health of military personnel serving in modern theaters. TBI incidence rates in Operation Enduring Freedom and Operation Iraqi Freedom approached 3% of all deployed personnel. Indeed, TBI has become known as the “signature” injury of these conflicts. Blast overpressure can also damage the lungs, eardrums, and eyes. Development ...

    STTR Phase II 2023 Department of DefenseDefense Health Agency
  6. Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus

    SBC: VAXSYNA, INC.            Topic: NCI

    Project Summary. Human papillomavirus (HPV) is a major public health concern due to 1) its implication in cancers of the anus, cervix, oropharynx, penis, vulva, and vagina; 2) global economic burden, and 3) vastly disproportionate impact on low-to-middle-income countries (LMIC). HPV-related cancers are responsible for 4.5% of all new cancer cases worldwide, 90% of HPV-related cervical cancer death ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  7. Low Cost Blast Test Surrogate

    SBC: CREARE LLC            Topic: DHA22B001

    Blast-induced Traumatic Brain Injury (TBI) is a major threat to the health of military personnel serving in modern theaters. TBI incidence rates in Operation Enduring Freedom and Operation Iraqi Freedom approached 3% of all deployed personnel. TBI has become known as the “signature” injury of these conflicts. Blast overpressure can also damage the lungs and rupture the eardrums. Development an ...

    STTR Phase I 2022 Department of DefenseDefense Health Agency
  8. A Novel Broad-spectrum Antiviral Agent

    SBC: CELDARA MEDICAL, LLC            Topic: NIAID

    Summary Accelerating emergence and re-emergence of a wide array of viral epidemics has been a deadly feature of the 21st century. Potent or even effective therapies are rarely available to combat these diseases, and in general, the world remains unprepared to manage future outbreaks. The most recent outbreak of the Ebola virus resulted in over 11,000 fatalities, more than 20,000 orphans, and econo ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  9. BandPass: A Remote Monitoring System for Sarcopenia and Functional Decline

    SBC: SYNCHROHEALTH LLC            Topic: NIA

    ABSTRACT Clinical Need: As the US population ages, managing pathologies that largely affect older adults, including sarcopenia (e.g., loss of muscle mass and strength), represents a significant and growing clinical challenge. In addition to increased rates of sarcopenia with age, it is well-accepted that its incidence and impact increases after acute illness, placing persons at additional risk for ...

    STTR Phase I 2021 Department of Health and Human ServicesNational Institutes of Health
  10. Reward-based technology to improve opioid use disorder treatment initiation after an ED visit

    SBC: Q2I, LLC            Topic: NIDA

    Project Summary/Abstract Millions of people in the US misuse opioids each year, leading to thousands of deaths and billions of dollars in total economic burden. Medications for opioid use disorder (MOUD) are highly efficacious, but only a fraction of people with Opioid Use Disorder (OUD) access MOUD, and further treatment non-adherence is common and is associated with poor outcomes. This applicati ...

    STTR Phase II 2021 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government